A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Plasmid Dna Expressing 2 Isoforms of Hepatocyte Growth Factor in Patients with Critical Limb Ischemia (original) (raw)

Profile image of Hau PhamHau Pham

2014, Journal of the American College of Cardiology

visibility

description

1 page

link

1 file

A phAse 2, double-blind, rAndomized, plAcebo-controlled, multicenter triAl oF the sAFety And eFFicAcy oF plAsmid dnA expressing 2 isoForms oF hepAtocyte growth FActor in pAtients with criticAl limb ischemiA

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact